GI
ANIP icon

GAMMA Investing’s ANI Pharmaceuticals ANIP Stock Holding History

GAMMA Investing’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$130K Buy
1,783
+211
+13% +$16.2K ﹤0.01% 1664
2026
Q2 		$130K Buy
1,572
+109
+7% +$8.74K ﹤0.01% 1610
2026
Q1 		$113K Buy
1,463
+41
+3% +$3.2K 0.01% 1579
2025
Q4 		$112K Sell
1,422
-83
-6% -$7.19K 0.01% 1494
2025
Q3 		$138K Buy
1,505
+126
+9% +$10.3K 0.01% 1239
2025
Q2 		$90K Sell
1,379
-40
-3% -$2.6K 0.01% 1532
2025
Q1 		$95K Buy
1,419
+881
+164% +$52.6K 0.01% 1303
2024
Q4 		$29.7K Sell
538
-14
-3% -$804 ﹤0.01% 2045
2024
Q3 		$32.9K Buy
552
+40
+8% +$2.44K ﹤0.01% 1782
2024
Q2 		$32.6K Buy
512
+51
+11% +$3.31K ﹤0.01% 1508
2024
Q1 		$31.9K Buy
461
+46
+11% +$2.78K 0.01% 1326
2023
Q4 		$23.2K Buy
+415
New +$22.9K 0.01% 1395

Other funds holding ANIP

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

GAMMA Investing's ANIP Position: Q3 2026 in Review

GAMMA Investing increased its ANI Pharmaceuticals (ANIP) stake by 13% in Q3 2026, buying an estimated $16.2K and bringing the position to 1,783 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

GAMMA Investing first reported a position in ANIP in Q4 2023 and has held it in 12 quarters since. The position peaked at $138K in Q3 2025. 6 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • GAMMA Investing held 1,783 shares of ANI Pharmaceuticals worth $130K as of Q3 2026.
  • GAMMA Investing bought 211 ANI Pharmaceuticals shares in Q3 2026, an estimated $16.2K.
  • ANI Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1664 holding.
  • GAMMA Investing first reported a position in ANI Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's ANI Pharmaceuticals position peaked at $138K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.